Beroctocog alfa

贝罗凝血素α

Report date: 2026/03/31 20:00:21

Base Information

Drug NameBeroctocog alfa
Drug Alias Name贝凝血素-8αBeroctocog alphaBeroctocog αBeroctocogum alfar-FVIII +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritorySouth Korea
Original Approved Date2009/12/01
Country/TerritoryCanadaUnited StatesUkraine +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesGC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A